Gsk Plc · LSE:GSK

Gsk — GlaxoSmithKline Consumer Healthcare — Q2 FY2017-18 Earnings Presentation

6 slides from Gsk's earnings presentation, 2017

Slide 1: GlaxoSmithKline Consumer Healthcare Limited Financial Results Q2 FY17-18
GlaxoSmithKline Consumer Healthcare Limited Financial Results Q2 FY17-18
Slide 2: Quarter Highlights
Quarter Highlights Revenue decreased by 6.5% : Underlying +4.8% On account of change in tax rate & tax regime: Excise, Value Added Tax (VAT) etc. have been subsumed into GST 3.6% increase in PBT • Continued investment behind brands: 12% of Sales (+8% growth) to fund innovation & drive Hlx campaign D
Slide 3: Financial Performance: Q2 FY18
Financial Performance*: Q2 FY18 Q2 FY 18 Q2 FY 17 Growth% Revenue from Operations 1115 1193 -6.5% EBITDA 261 245 6.6% PBT 298 288 3.6% 3% 5% 6% 5% 37% 95% 48% Domestic Exports North South East West Exports *Sales and profit growth v/s quarter ending Sep 2016 INR in crores
Slide 4: Market Share
Market Share Hlx 43.9% Horlicks Extensions 16.4% Boost 11.4% Source – AC Nielsen; Value Market Share MAT Sep 17
Slide 5: Horlicks new visualization: 'Defeating' nutritional deficiencies
Horlicks new visualization: ‘Defeating’ nutritional deficiencies
Slide 6: Thank You
Thank You